VHCP Management II’s Yarrow Bioscience YARW Stock Holding History

VHCP Management II’s Portfolio YARW Stock Details YARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-94	Closed	-$12.8M	–	22
2018 Q1	$12.8M	Buy	+94	New	+$11.4M	3.08%	11

Other funds holding YARW

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

VHCP Management II's YARW Position: Q2 2018 in Review

VHCP Management II sold out of Yarrow Bioscience (YARW) in Q2 2018, closing a stake of 94 shares — an estimated $12.8M sold.

VHCP Management II first reported a position in YARW in Q1 2018 and held it in 1 quarter. The position peaked at $12.8M in Q1 2018. 35 funds tracked by Wall St. Rank hold YARW as of Q2 2018.

VHCP Management II reported no remaining Yarrow Bioscience position as of Q2 2018 after selling out during the quarter.
VHCP Management II sold 94 Yarrow Bioscience shares in Q2 2018, an estimated $12.8M.
VHCP Management II first reported a position in Yarrow Bioscience in Q1 2018 and held it in 1 quarter.
VHCP Management II's Yarrow Bioscience position peaked at $12.8M in Q1 2018.
35 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q2 2018.

Based on VHCP Management II's 13F filing for Q2 2018, filed 13 Aug 2018.